Xiaodong Wang, Director at BeiGene, Ltd. (BGNE), sold 73,270 shares at $186.99 ($13.7M) on 2024-12-10, disclosed to the SEC on 2024-12-12.
Scheduled sale ($13.7M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $183.60 | 2,600 | $477K | 3.5% |
| 2 | $184.83 | 7,063 | $1.3M | 9.5% |
| 3 | $184.83 | 7,063 | $1.3M | 9.5% |
| 4 | $185.73 | 9,956 | $1.8M | 13.5% |
| 5 | $185.73 | 9,956 | $1.8M | 13.5% |
| 6 | $186.99 | 9,266 |
| $1.7M |
| 12.7% |
| 7 | $186.99 | 9,266 | $1.7M | 12.7% |
| 8 | $187.60 | 6,350 | $1.2M | 8.7% |
| 9 | $188.79 | 1,300 | $245K | 1.8% |
| 10 | $190.57 | 1,833 | $349K | 2.6% |
| 11 | $190.57 | 1,833 | $349K | 2.6% |
| 12 | $191.78 | 993 | $190K | 1.4% |
| 13 | $191.78 | 993 | $190K | 1.4% |
| 14 | $192.61 | 1,374 | $265K | 1.9% |
| 15 | $192.61 | 1,374 | $265K | 1.9% |
| 16 | $194.01 | 725 | $141K | 1.0% |
| 17 | $194.01 | 725 | $141K | 1.0% |
| 18 | $195.67 | 300 | $59K | 0.4% |
| 19 | $195.67 | 300 | $59K | 0.4% |
| Total | $186.93 avg | 73,270 | $13.7M | 100% |
| Filing → |
| ONC | SELL | 2025-06-25 | $668K | — | Filing → |
| ONC | SELL | 2025-06-12 | $21.9M | — | Filing → |
| BGNE | SELL | 2025-05-15 | $18.6M | — | Filing → |